cancer clinical trials in pittsfield, MA

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Colorectal Cancer

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Breast Cancer

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Prostate Cancer

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Berkshire Hematology Oncology, P.C.
Pittsfield, Massachusetts 01201

Breast Cancer

A Phase 3 Study to Compare Efficacy and Safety of Masitinib in Combination With Gemcitabine, to Placebo in Combination With Gemcitabine, in Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Berkshire Hematology Oncology
Pittsfield, Massachusetts 01201

Pancreatic Cancer

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Berkshire Hematology Oncology, P.C.
Pittsfield, Massachusetts 01201

Breast Cancer

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

Berkshie Hematology Oncology
Pittsfield, Massachusetts 01201

Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)

S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Lung Cancer

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Colorectal Cancer, Precancerous Condition

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Colorectal Cancer

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Adenocarcinoma of the Lung

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer

Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Colorectal Cancer

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Breast Cancer

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Berkshire Medical Center
Pittsfield, Massachusetts 01201

Breast Cancer

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Berkshire Medical Center
Pittsfield, Massachusetts 01201

Breast Cancer

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Berkshire Medical Center
Pittsfield, Massachusetts 01201

Breast Cancer

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Berkshire Medical Center
Pittsfield, Massachusetts 01201

Breast Cancer

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Berkshire Physicians and Surgeons, P.C.
Pittsfield, Massachusetts 01201

Breast Cancer

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Berkshire Medical Center
Pittsfield, Massachusetts 01201

Breast Cancer

Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Berkshire Physicians and Surgeons, P.C.
Pittsfield, Massachusetts 01201

Pancreatic Cancer

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

"For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
Pittsfield, Massachusetts

Colorectal Cancer

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Berkshire Hematology & Oncology, PC
Pittsfield, Massachusetts 012018298

Pancreatic Cancer

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

GSK Clinical Trials Call Center
Pittsfield, Massachusetts 01201

Small Cell Lung Cancer

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Non-small Cell Lung Cancer

REST: Reducing End-of-Life Symptoms With Touch

Hospice Care in the Berkshires, Inc.
Pittsfield, Massachusetts 01201

Neoplasms, Pain

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Berkshire Hematology Oncology
Pittsfield, Massachusetts 01201

Prostate Cancer, Hormone Refractory Prostate Cancer

Non-small Cell Lung Cancer Study US75 (Z-PACT)

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Non Small Cell Lung Carcinoma

Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Carcinoma, Non-Small-Cell Lung

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Lung Cancer, Non-small-cell Lung Carcinoma

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)

Berkshire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Berskhire Hematology Oncology PC
Pittsfield, Massachusetts 01201

Advanced Unresectable Pancreatic Cancer

Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients

Berkshire Hematology Oncology
Pittsfield, Massachusetts 01201

Multiple Myeloma

Cognition in the Study of Tamoxifen and Raloxifene

Berkshire Hematology Oncology, P.C.
Pittsfield, Massachusetts 01201

Cognition, Aging

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts 01201

Colorectal Cancer, Metastatic Cancer

Join the directory

Join the Community

Join the Directory